36 percent of millennials bear disproportionate burden of chronic illnesses: Redcliffe Labs study Ruchika Sharma6 April 2024 12:45 PM ISTRedcliffe Labs, a pan-India omnichannel diagnostics provider, has released a study unveiling stark generational differences in chronic disease...
Merck begins phase 3 trial of MK-1084, Keytruda combo for first-line treatment of certain patients with Metastatic Non-Small Cell Lung Cancer Ruchika Sharma6 April 2024 10:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced it has initiated a Phase 3 clinical trial evaluating MK-1084,...
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal For COPD Drug Study Dr. Divya Colin5 April 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
Dr Reddy's Labs arm introduces AI, machine learning assisted drug discovery platform Aurigene.AI Ruchika Sharma5 April 2024 3:17 PM ISTHyderabad: Aurigene Pharmaceutical Services Limited, a contract research, development, and manufacturing services organization and a Dr Reddy’s...
Cipla gets 6 USFDA observations for Maha facility Ruchika Sharma5 April 2024 11:51 AM ISTMumbai: Cipla has received six inspectional observations in Form 483 from the United States Food and Drug Administration (USFDA) at the...
FIRST: President of India unveils India's home-grown gene therapy for cancer Ruchika Sharma5 April 2024 11:30 AM ISTThe President was happy to note that the therapy being launched is the world's most affordable CAR-T cell therapy.
Blast at pharma plant premises, 6 people died till now Ruchika Sharma4 April 2024 4:18 PM ISTHyderabad: The toll in the explosion within a chemical reactor at a facility of pharmaceutical firm in the Telangana's Sangareddy district...
USFDA classifies Granules Pharma facility as Voluntary Action Indicated Ruchika Sharma4 April 2024 3:00 PM ISTHyderabad: Granules India has informed in a BSE filing that the United States Food and Drug Administration (USFDA) has classified the facility of...
Bristol Myers Squibb Reblozyl gets expanded European nod for anemia in lower risk Myelodysplastic Syndromes Ruchika Sharma4 April 2024 2:13 PM ISTPrinceton: Bristol Myers Squibb has announced that the European Commission (EC) has expanded approval of Reblozyl (luspatercept) to include...
Sun Pharmaceutical Industries appoints Dheeraj Sinha as Executive Vice President, Chief Information Officer Ruchika Sharma4 April 2024 11:30 AM ISTMumbai: Sun Pharmaceutical Industries Limited has appointed Dheeraj Sinha as Executive Vice President and Chief Information Officer effective from...
Lupin names Dr Ranjana Pathak as Chief Quality Officer Ruchika Sharma3 April 2024 5:36 PM ISTMumbai: Global pharma major Lupin Limited today announced the appointment of Dr Ranjana Pathak as Chief Quality Officer, succeeding Johnny Mikell...
Sudhir Mehta steps down as Director of Torrent Pharma Ruchika Sharma3 April 2024 4:09 PM ISTAhmedabad: Torrent Pharma has announced that Sudhir Mehta has stepped down as Director of the Company effective 31-Mar-24. He will continue to be...
